Victory Capital Management Inc. Reduces Stock Holdings in Option Care Health, Inc. (NASDAQ:OPCH)

Victory Capital Management Inc. reduced its position in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 6.6% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,984,306 shares of the company’s stock after selling 141,127 shares during the period. Victory Capital Management Inc.’s holdings in Option Care Health were worth $69,351,000 at the end of the most recent quarter.

Other institutional investors also recently added to or reduced their stakes in the company. Murphy & Mullick Capital Management Corp acquired a new position in shares of Option Care Health during the 4th quarter valued at about $26,000. Signaturefd LLC increased its position in Option Care Health by 487.9% in the 4th quarter. Signaturefd LLC now owns 1,211 shares of the company’s stock worth $28,000 after buying an additional 1,005 shares during the period. Bessemer Group Inc. boosted its stake in Option Care Health by 62.3% in the 1st quarter. Bessemer Group Inc. now owns 1,560 shares of the company’s stock valued at $54,000 after buying an additional 599 shares in the last quarter. Quadrant Capital Group LLC lifted its stake in Option Care Health by 172.8% in the fourth quarter. Quadrant Capital Group LLC now owns 1,735 shares of the company’s stock valued at $40,000 after buying an additional 1,099 shares during the period. Finally, Public Employees Retirement System of Ohio lifted its position in shares of Option Care Health by 21.6% in the fourth quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company’s stock valued at $43,000 after buying an additional 332 shares during the last quarter. Hedge funds and other institutional investors own 98.05% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on OPCH shares. JMP Securities reaffirmed a “market outperform” rating and issued a $36.00 target price on shares of Option Care Health in a report on Wednesday, June 18th. UBS Group upgraded shares of Option Care Health from a “neutral” rating to a “buy” rating and boosted their price objective for the stock from $38.00 to $40.00 in a report on Wednesday, April 30th. Finally, Barrington Research reaffirmed an “outperform” rating and issued a $38.00 target price on shares of Option Care Health in a report on Thursday, July 10th. One equities research analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Option Care Health has a consensus rating of “Moderate Buy” and a consensus target price of $35.50.

Option Care Health Trading Down 1.5%

NASDAQ OPCH opened at $29.94 on Friday. The business has a 50 day moving average price of $31.62 and a 200-day moving average price of $31.57. The company has a quick ratio of 1.02, a current ratio of 1.54 and a debt-to-equity ratio of 0.82. Option Care Health, Inc. has a 52 week low of $21.39 and a 52 week high of $35.53. The company has a market cap of $4.90 billion, a price-to-earnings ratio of 24.15, a P/E/G ratio of 1.84 and a beta of 0.73.

Option Care Health (NASDAQ:OPCH) last issued its quarterly earnings data on Tuesday, April 29th. The company reported $0.40 EPS for the quarter, topping the consensus estimate of $0.36 by $0.04. Option Care Health had a return on equity of 16.90% and a net margin of 4.12%. The company had revenue of $1.33 billion during the quarter, compared to analyst estimates of $1.26 billion. During the same quarter in the previous year, the company posted $0.26 earnings per share. Option Care Health’s revenue was up 16.3% compared to the same quarter last year. As a group, equities analysts expect that Option Care Health, Inc. will post 1.22 earnings per share for the current fiscal year.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.